The bivalent respiratory syncytial virus prefusion F vaccine is highly effective and well tolerated against RSV-associated ...
FOX 5 Atlanta on MSN6h
CDC: Signs point to potential COVID-19 uptick in GeorgiaNew data from the Centers for Disease Control and Prevention suggest Georgia could see a rise in COVID-19 cases in the coming ...
A study from Yale University today in JAMA Network Open reveals substantial protection by the preventive drug nirsevimab ...
In primary care settings, the burden of RSV on young children and their guardians often varied between the countries of ...
Among older adults in Spain, hospitalisation rates from respiratory syncytial virus (RSV) infection increases progressively ...
RSV leads to approximately 1.4 million hospitalizations and over 13,000 in-hospital deaths worldwide among infants under six ...
A single dose of respiratory syncytial virus vaccine was effective against infections and associated hospitalizations in veterans aged at least 60 years during the 2023-24 season.
COVID-19, influenza, RSV, bird flu and norovirus outbreaks converge across the U.S. and UMich campus
Simultaneous outbreaks of norovirus, birdflu, influenza, COVID-19 and respiratory syncytial virus are occurring across the ...
Influenza activity is still in high in Ohio, the Ohio Department of Health says, as COVID-19 deaths average up to 40 deaths a week.
Nirsevimab-resistant respiratory syncytial virus variants remain rare, but continued molecular surveillance is crucial. Read ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback